1657-6 |
11-Deoxycortisol |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
11-Deoxycortisol [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcg/dL; ng/dL |
|
|
|
|
|
|
CHEM |
|
1657-6 |
|
|
|
|
Both |
|
|
|
0 |
11DC SerPl-mCnc |
|
|
|
Y |
|
11DC; Chemistry; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
ng/dL;ug/mL |
|
|
|
0 |
16570-4 |
Centromere Ab |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Centromere Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
16570-4 |
|
IF |
|
|
Both |
|
|
|
0 |
Centromere Ab Ser Ql IF |
|
|
|
|
|
ABS; Aby; ACA; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cen; CRST syndrome; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16571-2 |
Cephadrine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cephadrine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16571-2 |
|
|
|
|
Both |
|
|
|
0 |
Cephadrine SerPl-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
16572-0 |
Cephaloridine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cephaloridine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
16572-0 |
|
|
|
|
Both |
|
|
|
0 |
Cephaloridine SerPl-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Loridine; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
16573-8 |
Cerebroside sulfatase |
ACnc |
Ser/Plas |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Cerebroside sulfatase [Presence] in Serum or Plasma |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16573-8 |
|
|
|
|
|
|
|
|
0 |
Deprecated Arylsulfatase A SerPl Ql |
|
|
|
|
|
Arbitrary concentration; Aryl sulfatase A; Arylsulfatase A; Chemistry; Metachromatic leucodystrophy; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16574-6 |
Cerebroside sulfatase |
CCnt |
Tiss |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cerebroside sulfatase [Enzymatic activity/mass] in Tissue |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16574-6 |
|
|
|
|
|
|
|
|
0 |
Deprecated Arylsulfatase A Tiss-cCnt |
|
|
|
|
|
Aryl sulfatase A; Arylsulfatase A; Catalytic Content; Chemistry; Metachromatic leucodystrophy; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16575-3 |
Cerebroside sulfatase B |
CCnc |
Urine |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cerebroside sulfatase B in urine |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16575-3 |
|
|
|
|
|
|
|
|
0 |
Deprecated Cerebroside sulfatase B Ur |
|
|
|
Y |
|
Aryl sulfatase A; Arylsulfatase A; Catalytic Concentration; Chemistry; Metachromatic leucodystrophy; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.4 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16576-1 |
Cerebroside sulfatase B |
CCnc |
Amnio fld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cerebroside sulfatase B in amniotic fluid |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16576-1 |
|
|
|
|
|
|
|
|
0 |
Deprecated Arylsulfatase A Amn-cCnc |
|
|
|
Y |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Aryl sulfatase A; Arylsulfatase A; Catalytic Concentration; Chemistry; Metachromatic leucodystrophy; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.4 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16577-9 |
Cerebroside sulfatase B |
CCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cerebroside sulfatase B in serum or plasma |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16577-9 |
|
|
|
|
|
|
|
|
0 |
Deprecated Cerebroside sulfatase B SerPl |
|
|
|
Y |
|
Aryl sulfatase A; Arylsulfatase A; Catalytic Concentration; Chemistry; Metachromatic leucodystrophy; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.4 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16578-7 |
Cerebroside sulfatase B |
CCnt |
Tiss |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cerebroside sulfatase B in tissue |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16578-7 |
|
|
|
|
|
|
|
|
0 |
Deprecated Cerebroside sulfatase B Tiss |
|
|
|
Y |
|
Aryl sulfatase A; Arylsulfatase A; Catalytic Content; Chemistry; Metachromatic leucodystrophy; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified |
2.4 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16579-5 |
Cerebroside sulfatase B |
CCnc |
Bld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cerebroside sulfatase B in blood |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16579-5 |
|
|
|
|
|
|
|
|
0 |
Deprecated Arylsulfatase A Bld-cCnc |
|
|
|
Y |
|
Aryl sulfatase A; Arylsulfatase A; Blood; Catalytic Concentration; Chemistry; Metachromatic leucodystrophy; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.4 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
1658-4 |
11-Hydroxyandrostenedione |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHEM |
|
1658-4 |
|
|
|
|
Both |
|
|
|
0 |
11OH-Ad SerPl-mCnc |
|
|
|
Y |
|
11-beta-hydroxyandrostenedione; 11-Hydroxy androstenedione; 11OH-Ad; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
16580-3 |
Cerebroside sulfatase B |
CCnc |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cerebroside sulfatase B in leukocytes |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
16580-3 |
|
|
|
|
|
|
|
|
0 |
Deprecated Cerebroside sulfatase B WBC |
|
|
|
Y |
|
Aryl sulfatase A; Arylsulfatase A; Catalytic Concentration; Chemistry; Leukocytes; Metachromatic leucodystrophy; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.4 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
16581-1 |
Chlamydophila pneumoniae Ab.IgA |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
16581-1 |
|
IF |
|
|
Both |
|
|
|
0 |
C pneum IgA Titr CSF IF |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Cerebral spinal fluid; Cerebrospinal Fl; Chlamydia; Chlamydia pneumoniae; CPN; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin A; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Twar agent |
2.75 |
1.0l |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
16582-9 |
Chlamydophila pneumoniae Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
16582-9 |
|
IF |
|
|
Both |
|
|
|
0 |
C pneum IgG Titr CSF IF |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Cerebral spinal fluid; Cerebrospinal Fl; Chlamydia; Chlamydia pneumoniae; CPN; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Twar agent |
2.75 |
1.0l |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
16583-7 |
Chlamydophila pneumoniae Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
16583-7 |
|
IF |
|
|
Both |
|
|
|
0 |
C pneum IgM Titr CSF IF |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C pneum; C pneumo; C pneumoniae; Cerebral spinal fluid; Cerebrospinal Fl; Chlamydia; Chlamydia pneumoniae; CPN; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Twar agent |
2.75 |
1.0l |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
16584-5 |
Chlamydophila pneumoniae rRNA |
PrThr |
Sputum |
Pt |
Ord |
Probe |
|
ACTIVE |
Chlamydophila pneumoniae rRNA [Presence] in Sputum by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16584-5 |
|
Probe |
|
|
Both |
|
|
|
0 |
C pneum rRNA Spt Ql Probe |
|
|
|
|
|
C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Lower respiratory; Lung; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; ribosomal RNA; Screen; Spt; Sputum; Twar agent |
2.63 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16585-2 |
Chlamydophila pneumoniae rRNA |
PrThr |
Ser/Plas |
Pt |
Ord |
Probe |
|
ACTIVE |
Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16585-2 |
|
Probe |
|
|
Both |
|
|
|
0 |
C pneum rRNA SerPl Ql Probe |
|
|
|
|
|
C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Twar agent |
2.63 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
16586-0 |
Chlamydophila psittaci Ab.IgA |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
16586-0 |
|
IF |
|
|
Both |
|
|
|
0 |
C psittaci IgA Titr CSF IF |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Avian chlamydiosis; C psittaci; Cerebral spinal fluid; Cerebrospinal Fl; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Dilution factor; Dilution Factor (Titer); Enzootic abortion of ewes; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin A; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ornithosis; Ovine chlamydiosis; Point in time; Psittacosis; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
1.0l |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
16587-8 |
Chlamydophila psittaci Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
16587-8 |
|
IF |
|
|
Both |
|
|
|
0 |
C psittaci IgG Titr CSF IF |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Avian chlamydiosis; C psittaci; Cerebral spinal fluid; Cerebrospinal Fl; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Dilution factor; Dilution Factor (Titer); Enzootic abortion of ewes; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ornithosis; Ovine chlamydiosis; Point in time; Psittacosis; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
1.0l |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
16588-6 |
Chlamydophila psittaci Ab.IgM |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16588-6 |
|
|
|
|
Both |
|
|
|
0 |
C psittaci IgM CSF-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Avian chlamydiosis; C psittaci; Cerebral spinal fluid; Cerebrospinal Fl; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Enzootic abortion of ewes; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ornithosis; Ovine chlamydiosis; Point in time; Psittacosis; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
16589-4 |
Chlamydia sp Ab |
ACnc |
Ser |
Pt |
Qn |
IF |
|
ACTIVE |
Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16589-4 |
|
IF |
|
|
Both |
|
|
|
0 |
Chlamydia Ab Ser IF-aCnc |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; Chlam; Chlamid; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR; Time Resolved Fluorescence; TRF |
2.73 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
1659-2 |
11-Hydroxyandrosterone |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
11-Hydroxyandrosterone [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
CHEM |
|
1659-2 |
|
|
|
|
Both |
|
|
|
0 |
11OH-Androst Ur-mCnc |
|
|
|
Y |
|
11-beta-hydroxyandrosterone; 11-Hydroxy androsterone; 11OH-Androst; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
16590-2 |
Chlamydia sp Ab |
ACnc |
Ser |
Pt |
Qn |
Comp fix |
|
ACTIVE |
Chlamydia sp Ab [Units/volume] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16590-2 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
Chlamydia Ab Ser CF-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CF; Chlam; Chlamid; Comp fixation; Compfix; Complement fixation; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
16591-0 |
Chlamydia sp Ab.IgG |
ACnc |
CSF |
Pt |
Qn |
IF |
|
ACTIVE |
Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
16591-0 |
|
IF |
|
|
Both |
|
|
|
0 |
Chlamydia IgG CSF IF-aCnc |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Chlam; Chlamid; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Time Resolved Fluorescence; TRF |
2.69 |
1.0l |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |